Worried About the Market? These Stocks Have a Track Record of Helping Investors Sleep at Night.
Axe Cap view
Defensive Dividend Growth Stocks Worth Watching Amid Volatility
Healthcare companies with steady dividends can anchor your portfolio when markets jitter.
South African investors often overlook the logical appeal of defensive sectors like healthcare, especially when sitting behind the rand’s recent swings. Stocks like Johnson & Johnson, while not JSE-listed, offer a compelling blueprint: decades of growing dividends and steady earnings even when markets tumble. UnitedHealth Group has had a bumpy recent ride, but its long-term dividend track record and exposure to rising healthcare demand globally make it a resilient choice. McKesson, a pharmaceutical distributor, similarly benefits from non-discretionary spending that tends to hold up in downturns. For rand-hedge reasons, these equities offer a diversification narrative beyond the usual resource-heavy JSE exposure. Should the rand weaken sharply against the dollar, these US-dollar-based dividend streams could help cushion portfolio volatility. Still, currency fluctuations pose risks, and sector-specific regulatory shocks could disrupt growth. But smart investors wanting to sleep better at night should take note of healthcare’s defensive dividend growth. this is just our opinion and not financial advice
Buy Johnson & Johnson and consider nibbling on UnitedHealth and McKesson for steady dividend exposure hedged by USD/ZAR movements. Trim resource-heavy JSE shares if your portfolio is too concentrated in cyclicals.
- JNJ
- UNH
- MCK
- USD/ZAR
- Rand depreciation beyond expectation
- Healthcare regulatory changes in US impacting earnings
6/10
The article recommends three healthcare dividend growth stocks for investors seeking portfolio stability during market volatility: Johnson & Johnson (a Dividend King with 64 consecutive years of dividend increases), UnitedHealth Group (rebounding after recent challenges with a 2.26% yield), and McKesson (the largest U.S. pharmaceutical distributor with steady dividend growth). Healthcare is highlighted as a defensive sector due to non-discretionary spending patterns.
Our take is based on reporting first published by The Motley Fool.